- Report
- July 2024
- 202 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- April 2023
- 156 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- October 2022
- 63 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- June 2023
- 111 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Drugs of Abuse market is a subset of the Addiction Disorders Drugs market, which focuses on the treatment of substance abuse and addiction. Drugs of Abuse are substances that are used for non-medical purposes and can lead to physical and psychological dependence. These drugs can be divided into two categories: illicit drugs, such as cocaine, heroin, and marijuana; and prescription drugs, such as opioids, benzodiazepines, and stimulants.
The Drugs of Abuse market is highly regulated, with governments and health organizations around the world working to reduce the prevalence of substance abuse and addiction. This includes initiatives such as public education campaigns, increased access to treatment, and stricter regulations on the sale and distribution of drugs.
Some of the major companies in the Drugs of Abuse market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Sanofi. These companies are involved in the development, manufacture, and distribution of drugs for the treatment of substance abuse and addiction. Show Less Read more